Trial Profile
Cannabidiol in patients with drug-refractory Crohn's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2013
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 26 Jun 2013 New trial record
- 18 May 2013 Results presented at the Digestive Disease Week 2013.